×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RVPH – reviva pharmaceuticals holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RVPH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/4
08:00 am
rvph
Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Medium
Report
Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
1/30
08:00 am
rvph
Reviva to Participate in the 2025 BIO CEO & Investor Conference
Low
Report
Reviva to Participate in the 2025 BIO CEO & Investor Conference
1/22
08:14 am
rvph
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) had its price target lowered by analysts at HC Wainwright from $14.00 to $11.00. They now have a "buy" rating on the stock.
Medium
Report
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) had its price target lowered by analysts at HC Wainwright from $14.00 to $11.00. They now have a "buy" rating on the stock.
1/21
08:02 am
rvph
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
High
Report
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
1/11
05:38 am
rvph
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Low
Report
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
1/10
11:57 am
rvph
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $7.00 price target on the stock.
Medium
Report
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $7.00 price target on the stock.
1/10
08:04 am
rvph
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $7.00 price target on the stock.
Medium
Report
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $7.00 price target on the stock.
1/7
08:35 am
rvph
Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit [Yahoo! Finance]
Low
Report
Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/14
04:18 pm
rvph
Form SCHEDULE 13G/A REVIVA PHARMACEUTICALS Filed by: Schonfeld Strategic Advisors LLC
Low
Report
Form SCHEDULE 13G/A REVIVA PHARMACEUTICALS Filed by: Schonfeld Strategic Advisors LLC
2/7
04:10 pm
rvph
Form SCHEDULE 13G/A REVIVA PHARMACEUTICALS Filed by: CVI Investments, Inc.
Low
Report
Form SCHEDULE 13G/A REVIVA PHARMACEUTICALS Filed by: CVI Investments, Inc.
1/31
09:31 pm
rvph
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: SAXENA PARAG
Medium
Report
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: SAXENA PARAG
12/23
11:31 am
rvph
Form SCHEDULE 13G REVIVA PHARMACEUTICALS Filed by: CVI Investments, Inc.
High
Report
Form SCHEDULE 13G REVIVA PHARMACEUTICALS Filed by: CVI Investments, Inc.
12/20
04:31 pm
rvph
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: Bhat Laxminarayan
High
Report
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: Bhat Laxminarayan
12/18
06:01 am
rvph
Form 8-K REVIVA PHARMACEUTICALS For: Dec 16
Medium
Report
Form 8-K REVIVA PHARMACEUTICALS For: Dec 16
12/18
06:01 am
rvph
Form 424B5 REVIVA PHARMACEUTICALS
Medium
Report
Form 424B5 REVIVA PHARMACEUTICALS
12/16
05:19 pm
rvph
Form 424B5 REVIVA PHARMACEUTICALS
High
Report
Form 424B5 REVIVA PHARMACEUTICALS
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: